TY - JOUR
T1 - Perspectives on NMR in drug discovery
T2 - A technique comes of age
AU - Pellecchia, Maurizio
AU - Bertini, Ivano
AU - Cowburn, David
AU - Dalvit, Claudio
AU - Giralt, Ernest
AU - Jahnke, Wolfgang
AU - James, Thomas L.
AU - Homans, Steve W.
AU - Kessler, Horst
AU - Luchinat, Claudio
AU - Meyer, Bernd
AU - Oschkinat, Hartmut
AU - Peng, Jeff
AU - Schwalbe, Harald
AU - Siegal, Gregg
N1 - Funding Information:
This article is based on a document drafted by I. B., C. L. and M. P., during the workshop ‘Perspectives of NMR in Drug Discovery’ held in Florence April 2007. Financial support by the NMR-Life Coordination Action LSHG-CT-2005-018,758, by Ente CR Firenze and by MCYT-FEDER (Bio2005-00295) is gratefully acknowledged. We thank M. Fragai and C. Lipinski for suggestions and comments. We also thank L. Slivka for careful assistance in the preparation of the manuscript.
PY - 2008/9/1
Y1 - 2008/9/1
N2 - In the past decade, the potential of harnessing the ability of nuclear magnetic resonance (NMR) spectroscopy to monitor intermolecular interactions as a tool for drug discovery has been increasingly appreciated in academia and industry. In this Perspective, we highlight some of the major applications of NMR in drug discovery, focusing on hit and lead generation, and provide a critical analysis of its current and potential utility.
AB - In the past decade, the potential of harnessing the ability of nuclear magnetic resonance (NMR) spectroscopy to monitor intermolecular interactions as a tool for drug discovery has been increasingly appreciated in academia and industry. In this Perspective, we highlight some of the major applications of NMR in drug discovery, focusing on hit and lead generation, and provide a critical analysis of its current and potential utility.
UR - http://www.scopus.com/inward/record.url?scp=51249121331&partnerID=8YFLogxK
U2 - 10.1038/nrd2606
DO - 10.1038/nrd2606
M3 - Article
C2 - 19172689
AN - SCOPUS:51249121331
SN - 1474-1776
VL - 7
SP - 738
EP - 745
JO - Nature Reviews Drug Discovery
JF - Nature Reviews Drug Discovery
IS - 9
ER -